Taichi for Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)
Taichi for Overweight/Obese Adolescent and Young Women With Polycystic Ovary Syndrome (PCOS)
The present study is a randomized pilot study, overweight/obese adolescent and young PCOS
 subjects will be assigned into two groups: Taichi arm and control arm. Hormonal profile and
 metabolic profile will be determined.
Inclusion Criteria:

 -  Women aged between 19 and 35 years;

 -  Diagnosis of PCOS according to the modified Rotterdam criteria;

 -  2 years after menarche;

 -  Body mass index (BMI) equal to or greater than 23 kg/m*m.

 Exclusion Criteria:

 -  Administration of other medications known to affect reproductive function or
 metabolism within the past three months, including oral contraceptives,
 Gonadotropin-releasing hormone (GnRH) agonists and antagonists, anti androgens,
 gonadotropins, anti-obesity drugs, Chinese herbal medicines, anti diabetic drugs such
 as metformin and thiazolidinediones, somatostatin, diazoxide, and calcium channel
 blockers.

 -  Patients with other endocrine disorder including 21-hydroxylase deficiency,
 hyperprolactinemia, uncorrected thyroid disease, suspected Cushing's syndrome.

 -  Patients with known severe organ dysfunction or mental illness.